• HyperPFU™ high-fidelity DNA polymerase guide

  2026-08-29

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It produces blunt-ended PCR products for cloning and sequencing, but is not the appropriate choice when a workflow requires 3′-A overhangs or preformed sticky ends.

• Tin Mesoporphyrin IX: A Causal HO Probe

  2026-08-28

  Tin Mesoporphyrin IX (chloride) enables researchers to move beyond HO-1 expression measurements and test whether heme oxygenase activity causally shapes ROS, heme catabolism, and viral phenotypes. This article develops an assay-to-mechanism framework grounded in recent HBV research and practical experimental controls.

• Gap26: Connexin 43 Mimetic Peptide Workflows

  2026-08-28

  Gap26 gives researchers a practical way to interrupt connexin 43-dependent communication while tracking calcium waves, ATP release, and mitochondrial transfer. This guide translates validated product parameters and a 2025 liver-graft study into cell, tissue, and in vivo workflows with controls that help distinguish channel blockade from nonspecific toxicity.

• Nullscript: A Histone Deacetylase Inhibitor

  2026-08-27

  Nullscript is a histone deacetylase inhibitor and close analog of scriptaid with an unusual transcriptional-facilitation profile. Product information reports approximately 46.8% in vivo myocardial infarct size reduction in a murine cardiac ischemia/reperfusion model, but no clinical evidence is available.

• Oridonin and Inflammation in Esophageal Cancer

  2026-08-27

  A 2025 mouse study links oridonin’s anti-esophageal-cancer effects to suppression of the TLR4/NF-κB/NLRP3 inflammasome axis. Its integrated use of histopathology, inflammatory biomarkers, hematology, qPCR, and western blotting provides a mechanistic framework for studying inflammation-driven tumor progression, while its findings remain preclinical and model dependent.

• M344 for Reliable Cell-Based Assays

  2026-08-26

  Learn how M344 (SKU A4105) supports reproducible cell viability, proliferation, differentiation, and cytotoxicity workflows. This scenario-driven guide connects mechanism, dosing, solubility, controls, and vendor-selection criteria for evidence-based laboratory decisions.

• γH2AX DNA Damage Detection Kit for DSB Workflows

  2026-08-26

  Turn radiation, nanoparticle, and genotoxicity experiments into spatially resolved measurements of DNA double-strand breaks with a red γ-H2AX signal and blue nuclear counterstain. This practical guide explains assay setup, quantitative imaging, repair kinetics, and troubleshooting for research models ranging from cultured cells to tissue sections.

• Degarelix Acetate and Rapid Prostate Cancer Control

  2026-08-25

  Laurence Klotz’s review examines degarelix acetate as a third-generation GnRH antagonist designed to achieve rapid medical castration without the testosterone surge associated with GnRH agonists. The paper’s clinical-trial synthesis highlights faster testosterone suppression, an early prostate-specific antigen response, and a safety profile broadly comparable to agonist therapy in advanced prostate cancer.

• Bone Transport, TGF-β1, and Diabetic Foot Ulcer Repair

  2026-08-25

  A 2026 rat study shows that bone transport accelerates ischemic diabetic foot ulcer healing through coordinated TGF-β1/TGFBR1 activation, angiogenesis, and immune regulation. Its inhibitor-based design and multimodal molecular analysis position TGF-β1 signaling as a mechanistic bridge between bone regeneration and chronic wound repair.

• Berbamine hydrochloride: NF-κB Research Workflows

  2026-08-24

  Build reproducible cytotoxicity and mechanism-focused assays with Berbamine hydrochloride across leukemia and hepatocellular carcinoma models. This workflow separates product-backed activity from exploratory ferroptosis hypotheses, helping researchers connect NF-κB and STAT3 readouts with the METTL16-SENP3-LTF framework.

• Stat3 and NF-κB in Fyn-Driven Neurodegeneration

  2026-08-24

  A 2024 Disease Models & Mechanisms study uses a neural-specific zebrafish model of constitutively active Fyn to connect dopaminergic neuron loss with microglial inflammation. Live imaging, transcriptomics, and pathway inhibition identify Stat3 as a downstream Fyn effector that cooperates with NF-κB, providing a mechanistic framework for studying kinase-associated neurodegeneration.

• Exendin-4 Workflows for Type 2 Diabetes Research

  2026-08-23

  Build more informative beta-cell, cAMP, insulin-sensitivity, and hepatic-steatosis assays with Exendin-4 (Exenatide). This practical guide connects controlled peptide workflows with a 2024 yeast-expression strategy, helping researchers distinguish assay optimization from translational production claims.

• Methyl-β-cyclodextrin: Membrane Workflow Guide

  2026-08-22

  Methyl-β-cyclodextrin is a research reagent for controlled membrane cholesterol extraction and related studies of membrane organization, fluidity, and signaling. This dossier-based guide provides handling and QC recommendations, while noting that concentration, exposure time, and biological outcomes must be established for each experimental system and that the product is not intended for clinical or diagnostic use.

• Firefly Luciferase mRNA as a Delivery Diagnostic

  2026-08-22

  Firefly Luciferase mRNA can do more than report gene expression: it can help separate delivery, endosomal escape, and translation in advanced mRNA workflows. This article connects 5-moUTP chemistry with rhamnolipid-stabilized nanoparticles while defining practical controls and interpretation limits.

• Resiniferatoxin and TRPV1-Positive Afferents

  2026-08-21

  Szallasi’s 2023 review positions Resiniferatoxin (RTX) as an ultra-potent TRPV1 agonist that can progress from transient sensory excitation to prolonged desensitization or ablation of TRPV1-positive afferents. Its analysis connects molecular pharmacology with intravesical, intra-articular, veterinary, and targeted neuraxial applications, while emphasizing route, exposure, and translational safety as key determinants of outcome.

8038 records 1/536 page Next 12345 下5页 Last page